Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer C Price

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Open Forum Infectious Diseases|July 16, 2019
High Kynurenine:Tryptophan Ratio Is Associated With Liver Fibrosis in HIV-Monoinfected and HIV/Hepatitis C Virus-Coinfected WomenAni Kardashian, Yifei Ma, Michael T Yin, et al.
Annals of Gastroenterology|January 3, 2017
Perceptions of fecal microbiota transplantation for <i>Clostridium difficile</i> infection: factors that predict acceptanceLeslie Park, Anjali Mone, Jennifer C Price, et al.
Open Forum Infectious Diseases|January 1, 2026
Assessment of RNA at SVR4 and Treatment Completion as Alternative Measures of Hepatitis C Cure for People Who Inject DrugsClaire McDonell, Ryan Assaf, Jeff McKinney, et al.
Trials|January 23, 2025
A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You're Empowered for Treatment Initiation (YETI) partner trialMeghan D Morris, Judy Y Tan, Claire C McDonell, et al.
Hepatology (Baltimore, Md.)|December 17, 2016
Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infectionJennifer C Price, Yifei Ma, Rebecca Scherzer, et al.
AIDS (London, England)|January 13, 2017
Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adultsMichael Reid, Yifei Ma, Rebecca Scherzer, et al.
JAMA Network Open|July 21, 2023
Trends in the Prevalence of Hepatitis C Infection During Pregnancy and Maternal-Infant Outcomes in the US, 1998 to 2018Po-Hung Chen, Lauren Johnson, Berkeley N Limketkai, et al.
The International Journal on Drug Policy|March 15, 2025
Facilitating access to direct-acting antivirals in a community-based point-of-diagnosis model for hepatitis C treatment: The role of the pharmacy team in the no one waits (NOW) studyColleen A McGourty, Diana Ung, Mackenzie Clark, et al.
The Journal of Infectious Diseases|November 22, 2018
Sexually Acquired Hepatitis C Infection in HIV-Uninfected Men Who Have Sex With Men Using Preexposure Prophylaxis Against HIVJennifer C Price, Jeffrey E McKinney, Pierre-Cedric Crouch, et al.
Hepatology Communications|June 27, 2025
Feasible and acceptable social drivers of health screening among patients with chronic liver diseaseRebecca G Kim, April Ballantyne, Rachel R Codden, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Open Forum Infectious Diseases|July 16, 2019
High Kynurenine:Tryptophan Ratio Is Associated With Liver Fibrosis in HIV-Monoinfected and HIV/Hepatitis C Virus-Coinfected WomenAni Kardashian, Yifei Ma, Michael T Yin, et al.
Annals of Gastroenterology|January 3, 2017
Perceptions of fecal microbiota transplantation for <i>Clostridium difficile</i> infection: factors that predict acceptanceLeslie Park, Anjali Mone, Jennifer C Price, et al.
Open Forum Infectious Diseases|January 1, 2026
Assessment of RNA at SVR4 and Treatment Completion as Alternative Measures of Hepatitis C Cure for People Who Inject DrugsClaire McDonell, Ryan Assaf, Jeff McKinney, et al.
Trials|January 23, 2025
A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You're Empowered for Treatment Initiation (YETI) partner trialMeghan D Morris, Judy Y Tan, Claire C McDonell, et al.
Hepatology (Baltimore, Md.)|December 17, 2016
Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infectionJennifer C Price, Yifei Ma, Rebecca Scherzer, et al.
AIDS (London, England)|January 13, 2017
Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adultsMichael Reid, Yifei Ma, Rebecca Scherzer, et al.
JAMA Network Open|July 21, 2023
Trends in the Prevalence of Hepatitis C Infection During Pregnancy and Maternal-Infant Outcomes in the US, 1998 to 2018Po-Hung Chen, Lauren Johnson, Berkeley N Limketkai, et al.
The International Journal on Drug Policy|March 15, 2025
Facilitating access to direct-acting antivirals in a community-based point-of-diagnosis model for hepatitis C treatment: The role of the pharmacy team in the no one waits (NOW) studyColleen A McGourty, Diana Ung, Mackenzie Clark, et al.
The Journal of Infectious Diseases|November 22, 2018
Sexually Acquired Hepatitis C Infection in HIV-Uninfected Men Who Have Sex With Men Using Preexposure Prophylaxis Against HIVJennifer C Price, Jeffrey E McKinney, Pierre-Cedric Crouch, et al.
Hepatology Communications|June 27, 2025
Feasible and acceptable social drivers of health screening among patients with chronic liver diseaseRebecca G Kim, April Ballantyne, Rachel R Codden, et al.
Pageof 10